Letter: Epipodophyllotoxin VP 16213 in acute non-lymphoblastic leukaemia.
D003561:Cytarabine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D011034:Podophyllotoxin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use
D013876:Thiophenes; D003561:Cytarabine; D004317:Doxorubicin; D011034:Podophyllotoxin